Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Medicaid: Changes in Drug Prices Paid by HMOs and Hospitals Since Enactment of Rebate Provisions

HRD-93-43 Published: Jan 15, 1993. Publicly Released: Jan 15, 1993.
Jump To:
Skip to Highlights

Highlights

GAO reported on changes in drug prices charged to health maintenance organizations (HMO) and hospital group purchasing organizations (GPO) under rebate provisions of the Omnibus Budget Reconciliation Act of 1990, which required that drug manufacturers give state Medicaid programs rebates for outpatient drugs.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

DrugsHealth care cost controlHealth care costsHealth maintenance organizationsHospitalsMedicaidPharmaceutical industryPrice adjustmentsPrice regulationPrices and pricingPrescription drugs